Stock Price Movement and Market Context
On 17 Mar 2026, TTK Healthcare’s stock opened with a gap down of -2.14%, hitting an intraday low of Rs 807.05, which is just 4.04% above its 52-week low. Despite this, the stock managed a modest recovery, outperforming its sector by 1.24% and reversing a two-day consecutive decline. However, the share price remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend.
In comparison, the broader market showed resilience with the Nifty closing at 23,581.15, up 0.74%. The Nifty Midcap 100 index led gains with a 1.02% increase, while the Nifty itself trades below its 50-day moving average, which is also positioned below the 200-day moving average, indicating a cautious market environment.
Long-Term Performance and Valuation Metrics
Over the last year, TTK Healthcare’s stock has declined by 23.70%, significantly underperforming the Sensex, which posted a 2.56% gain over the same period. The stock’s 52-week high was Rs 1,398.90, highlighting the extent of the recent downward movement. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index across one-year, three-year, and three-month timeframes.
Financially, the company has exhibited modest growth with net sales increasing at an annualised rate of 6.99% and operating profit growing at 15.42% over the past five years. Despite these figures, the overall growth trajectory has been considered subdued relative to sector peers.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Financial Health and Profitability Indicators
TTK Healthcare’s cash and cash equivalents stood at Rs 600.89 crores in the half-year period, marking the lowest level recorded recently. The company’s debtors turnover ratio also declined to 7.40 times, indicating slower collection efficiency. Notably, non-operating income accounted for 80.43% of the quarterly profit before tax, suggesting a significant reliance on income sources outside core operations.
The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure. Return on equity (ROE) is reported at 6.5%, which, while modest, contributes to an attractive valuation with a price-to-book value ratio of 1.1. However, the stock trades at a premium relative to its peers’ historical valuations, which may be a factor in its subdued market performance.
Market Participation and Shareholding Patterns
Despite its micro-cap status, domestic mutual funds hold a minimal stake of just 0.01% in TTK Healthcare. Given that mutual funds typically conduct thorough research before investing, this limited exposure could reflect reservations about the company’s current valuation or business prospects.
Over the past year, while the stock price has declined by 23.70%, the company’s profits have increased marginally by 2.4%. This disparity is reflected in a high PEG ratio of 7.1, indicating that the stock’s price may not be fully supported by its earnings growth.
Technical Analysis Overview
Technical indicators present a predominantly bearish outlook for TTK Healthcare. The Moving Average Convergence Divergence (MACD) is bearish on both weekly and monthly charts. Bollinger Bands also signal bearish momentum across these timeframes. The daily moving averages confirm this trend, with the stock trading below all key averages.
Other technical tools such as the Know Sure Thing (KST) indicator and Dow Theory assessments show mild bearishness on weekly and monthly scales. The Relative Strength Index (RSI) offers a mixed signal, with a bullish indication on the monthly chart but no clear trend weekly. On-balance volume (OBV) analysis reveals no definitive trend weekly and mild bearishness monthly.
Holding TTK Healthcare Ltd. from Diversified? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Ratings and Market Position
TTK Healthcare currently holds a Mojo Score of 37.0 with a Mojo Grade of Sell, downgraded from Hold as of 21 Jul 2025. The company’s market capitalisation is classified as micro-cap, reflecting its relatively small size within the diversified sector. This rating aligns with the stock’s recent price performance and financial metrics, underscoring the challenges faced by the company in delivering sustained growth and shareholder returns.
While the stock has shown some short-term resilience by gaining after two days of decline, the overall trend remains subdued. The combination of below-average sales growth, limited mutual fund participation, and technical indicators suggests that the stock is navigating a difficult phase within a broader market that is currently more favourable to mid-cap segments.
Conclusion
TTK Healthcare Ltd.’s fall to its 52-week low of Rs 807.05 highlights a period of underperformance relative to both the broader market and its sector peers. The stock’s valuation, financial indicators, and technical signals collectively point to ongoing challenges in regaining upward momentum. Investors and market participants will continue to monitor the company’s financial disclosures and market developments to assess any shifts in this trajectory.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
